Manoj J. Monga, MD, FACS presented “Controversies in Percutaneous Nephrolithotomy” during the 42nd Annual Ralph E. Hopkins Urology Seminar on February 1, 2023, in Jackson Hole, Wyoming.
How to cite: Monga, Manoj J. “Controversies in Percutaneous Nephrolithotomy.” February 1, 2023. Accessed Nov 2025. https://grandroundsinurology.com/controversies-in-percutaneous-nephrolithotomy/
Controversies in Percutaneous Nephrolithotomy – Summary
Manoj J. Monga, MD, FACS examines the indications for PCNL, emphasizing the criteria that influence the decision to opt for this invasive treatment. He highlights differing opinions on patient selection and the importance of individualized treatment plans.
Dr. Monga focuses on the technical aspects of PCNL and various approaches and techniques. He reviews the debate over the optimal access points, upper pole versus lower pole entry, and the risks and benefits of miniaturized versus standard tracts. He analyzes outcomes related to stone clearance rates, complications, and recovery times. Dr. Monga further explores the controversies in postoperative management, particularly the use of nephrostomy tubes versus tubeless procedures.
Emerging technologies and innovations in PCNL are also a key part of this presentation. Advancements in imaging techniques, new instruments, and their potential to enhance the safety and effectiveness of the procedure are examined, as well as the need for ongoing research.
About The 42nd Annual Ralph E. Hopkins Urology Seminar:
The Ralph E. Hopkins Urology Seminar is a multi-day meeting focused on training urologists in the latest in assessing, diagnosing, and treating urologic conditions in the clinical setting. Updates are provided on urologic cancers, stone disease, urologic reconstruction, female urology, infertility, sexual function, emerging surgical techniques, and general urology. The 42nd iteration of the meeting took place from February 1st to 4th, 2023, in Jackson Hole, Wyoming.
For further educational activities from this conference, visit our collection page.
ABOUT THE AUTHOR
Manoj J. Monga, MD, FACS, FRCS, is a Professor and the Chair of the Department of Urology at the University of California, San Diego, where he oversees the department’s research, teaching, and clinical care. He is recognized as an international authority in endourology (minimally invasive urologic surgery) and kidney stone disease. His clinical expertise includes kidney stone prevention, medical and surgical management of kidney stone disease, and endoscopic management of upper tract transitional cell cancer and benign strictures.
